"Services at Ohio State Martha Morehouse Outpatient Care include cancer treatment, physical therapy, bariatric care, sleep medicine and wellness and prevention."

During the past decade, Martha Morehouse Medical Plaza conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 7 clinical trials were completed, i.e. on average, 41.2% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 6 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Martha Morehouse Medical Plaza" #1 sponsor was "Pfizer" with 10 trials, followed by "Ohio State University" with 7 trials sponsored, "United Therapeutics" with 2 trials sponsored, "Amgen" with 1 trials sponsored and "Gayle Gordillo" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Martha Morehouse Medical Plaza" #1 collaborator was "Nationwide Children's Hospital" with 2 trials as a collaborator, "Natreon, Inc." with 2 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Medical University of South Carolina" with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Martha Morehouse Medical Plaza" are "Neoplasms" (2 trials), "Wound" (2 trials), "Advanced Cancer" (1 trials), "Advanced Hepatocellular Carcinoma" (1 trials) and "Advanced Malignancies Except Leukemia" (1 trials). Many other conditions were trialed in "Martha Morehouse Medical Plaza" in a lesser frequency.

Most popular intervention types in "Martha Morehouse Medical Plaza" are "Drug" (13 trials), "Device" (3 trials), "Dietary Supplement" (3 trials), "Diagnostic Test" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "5-FU" (1 trials), "Avelumab" (1 trials), "Axitinib" (1 trials) and "Bevacizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Martha Morehouse Medical Plaza" are 21 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Martha Morehouse Medical Plaza". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Martha Morehouse Medical Plaza, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Martha Morehouse Medical Plaza, 7 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".